Today, Oncolytics Bio shares closed at $1.69 after opening the day at $1.62. It traded at a low of $1.60 to a high of $1.74.
3 days ago

Oncolytics Bio opened trading today at $1.63 and closed at $1.62. Intraday prices ranged from a low of $1.59 to a high of $1.63.
4 days ago

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to...
1 month ago

Today, shares of Oncolytics Bio opened at $1.64 and closed at $1.62. prices ranged from a low of $1.59 to a high of $1.64.
5 days ago

Results met efficacy criteria for enrollment expansion and provide support for pelareorep's mechanism of action. SAN DIEGO and CALGARY, AB,...
6 months ago

A team at City of Hope recently engineered a virus to produce a truncated version of CD19 in solid tumor cells, thereby making the cells...
38 months ago

Detailed price information for Oncolytics Bio (ONC-T) from The Globe and Mail including charting and trades.
3 days ago

Glioblastoma multiforme (GBM) is the most common malignant primary brain cancer affecting the adult population. Median overall survival for...
3 months ago

Today in trading, shares of Oncolytics Bio opened at $1.61 and closed at $1.61. prices ranged from $1.60 to $1.62. Shares surged 0.63 percent from the...
6 days ago

Oncolytic viruses (OVs) for cancer treatment are in a rapid stage of development, and the direct tumor lysis and activation of a...
5 months ago